Impact of Merkel Cell Polyomavirus Antibody in Tumor and Plasma Specimens
Author Information
Author(s): Schmocker Ryan K. MD, MS, FACS, Enomoto Laura M. MD, MSc, FACS
Primary Institution: Department of Surgery, University Surgical Oncology, University of Tennessee Graduate School of Medicine, Knoxville, TN USA
Hypothesis
Does the presence of MCPyV-Ab in tumor specimens provide prognostic information similar to that in plasma specimens?
Conclusion
The study suggests that tumor MCPyV-Ab positivity may serve as a prognostic factor for disease-free survival and overall survival.
Supporting Evidence
- Patients with plasma MCPyV-Ab positive experienced significantly longer disease-free survival compared to those who were MCPyV-Ab negative.
- The study discovered two subgroups of patients with discordance between tumor and plasma MCPyV-Ab status.
Takeaway
This study looks at a virus that can cause skin cancer and finds that checking for it in tumor samples might help doctors understand how well patients will do.
Methodology
The study investigated the impact of MCPyV-Ab in tumor tissue and compared it with plasma MCPyV-Ab status.
Limitations
The rarity of the disease may require a multi-institutional cohort for more definitive conclusions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website